Reduced BCR signaling together with increased co-localization of the inhibitory co-receptor CD22 and SHP-1 in RA, pSS, and most pronounced in SLE B cells and increased PTP activities in SLE B cells may reflect a phenotype related to anergy (76–80). This evidence concerns the gene CD22 and systemic lupus erythematosus.